Incyte a " Life After Debt

Full story: The Biotech Stock Blog

Incyte a ' Life After Debt For part I click here On top its JAK programs, Incyte has been developing two additional programs it intends to out-license. The first program is INCB13739 for diabetes, which already reached clinical proof of concept and could be licensed imminently.

Leave a Comment

Comments

Type in your comments to post to the forum

Name
(appears on your post)

Comments

Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Avandia, Rosiglitazone Discussions

Topic	Updated	Last By	Comments
Avandia (Jan '06)	Nov 13	Neill	61
Buy Avandia (Rosiglitazone 2/4/8mg )Indian onli...	Nov 12	Keven	4
ADA 2009: RECORD results: rosiglitazone doubles...	Sep '09	irsharonq	1
New Treatment for Tough Disease	Jun '09	T2DM Patient	1
Avandia Heart Risk Forum (Jun '07)	Apr '09	Susan	12
FDA Wants New Diabetes Drugs Tested for Heart R... (Jan '09)	Apr '09	Howard	2
Lots of Ink: Diabetes doubles in US, new drugs ... (Oct '08)	Oct '08	Frank Miller	1